Literature DB >> 15431218

Development of streptomycin resistant strains of tubercle bacilli in pulmonary tuberculosis; results of simultaneous sensitivity tests in liquid and on solid media.

D A MITCHISON.   

Abstract

Entities:  

Keywords:  STREPTOMYCIN; TUBERCLE BACILLI; TUBERCULOSIS, PULMONARY

Mesh：

Substances：

Year:  1950        PMID： 15431218      PMCID： PMC1018328          DOI： 10.1136/thx.5.2.144

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  3 in total

1.  STREPTOMYCIN-DEPENDENT TUBERCLE BACILLI: A SIMPLE METHOD FOR ISOLATION.

Authors:  D Yegian; V Budd; R J Vanderlinde
Journal:  J Bacteriol       Date:  1949-08       Impact factor: 3.490

2.  A Quantitative Analysis of the Resistance of Mycobacteria to Streptomycin.

Authors:  D Yegian; R J Vanderlinde
Journal:  J Bacteriol       Date:  1948-08       Impact factor: 3.490

3.  Distribution of streptomycin-sensitive tubercle bacilli in lungs of a resistant patient.

Authors:  A R ARMSTRONG; A M WALKER
Journal:  Can Med Assoc J       Date:  1949-04       Impact factor: 8.262
  3 in total
  10 in total

1.  The clinical significance of positive cultures and of isoniazid-resistant tubercle bacilli during the treatment of pulmonary tuberculosis; report to the Tuberculosis Chemotherapy Trials Committee of the Medical Research Council.

Authors:  W FOX; I SUTHERLAND
Journal:  Thorax       Date:  1955-06       Impact factor: 9.139

2.  Recent advances in tuberculosis: New drugs and treatment regimens.

Authors:  Derek J Sloan; Geraint R Davies; Saye H Khoo
Journal:  Curr Respir Med Rev       Date:  2013-06-01

3.  Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.

Authors:  Annika Krüüner; Malcolm D Yates; Francis A Drobniewski
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

4.  Cryptic Microheteroresistance Explains Mycobacterium tuberculosis Phenotypic Resistance.

Authors:  John Z Metcalfe; Elizabeth Streicher; Grant Theron; Rebecca E Colman; Christopher Allender; Darrin Lemmer; Rob Warren; David M Engelthaler
Journal:  Am J Respir Crit Care Med       Date:  2017-11-01       Impact factor: 21.405

Review 5.  The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: part I: the origins and nature of the problem.

Authors:  Jerrold J Ellner
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

6.  [Contribution to the problem of resistance stability of the so-called polyresistant mycobacteria from patients with widespread chronic pulmonary tuberculosis].

Authors:  J Tousek; L Trnka; A Havel
Journal:  Beitr Klin Erforsch Tuberk Lungenkr       Date:  1968

7.  Mycobacterium avium strains resistant to clarithromycin and azithromycin.

Authors:  L Heifets; N Mor; J Vanderkolk
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

Review 8.  From Kiyoshi Shiga to Present-Day Shigella Vaccines: A Historical Narrative Review.

Authors:  Crystal M Herrera; Jessicia S Schmitt; Erum I Chowdhry; Mark S Riddle
Journal:  Vaccines (Basel)       Date:  2022-04-20

Review 9.  Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application.

Authors:  Christopher A Kerantzas; William R Jacobs
Journal:  mBio       Date:  2017-03-14       Impact factor: 7.867

10.  The evolution of a neglected disease: tuberculosis discoveries in the centuries.

Authors:  N Riccardi; D Canetti; M Martini; M M Diaw; A DI Biagio; L Codecasa; I Barberis; N L Bragazzi; G Besozzi
Journal:  J Prev Med Hyg       Date:  2020-04-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.